日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression

FGFR抑制剂通过消除免疫抑制作用,增强抗PD-1疗法在小鼠FGFR3突变型膀胱癌中的疗效。

Atsushi Okato ,Takanobu Utsumi ,Michela Ranieri ,Xingnan Zheng ,Mi Zhou ,Luiza D Pereira ,Ting Chen ,Yuki Kita ,Di Wu ,Hyesun Hyun ,Hyojin Lee ,Andrew S Gdowski ,John D Raupp ,Sean Clark-Garvey ,Ujjawal Manocha ,Alison Chafitz ,Fiona Sherman ,Janaye Stephens ,Tracy L Rose ,Matthew I Milowsky ,Sara E Wobker ,Jonathan S Serody ,Jeffrey S Damrauer ,Kwok-Kin Wong ,William Y Kim

Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC

组蛋白去乙酰化酶 6 抑制剂可利用 LKB1 突变、KRAS 驱动的 NSCLC 中的选择性代谢弱点

Hua Zhang, Christopher S Nabel, Dezhi Li, Ruth Í O'Connor, Caroline R Crosby, Sarah M Chang, Yuan Hao, Robyn Stanley, Soumyadip Sahu, Daniel S Levin, Ting Chen, Sittinon Tang, Hsin-Yi Huang, Mary Meynardie, Janaye Stephens, Fiona Sherman, Alison Chafitz, Naoise Costelloe, Daniel A Rodrigues, Hilda F

Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

Nemvaleukin alfa 是一种新型工程化 IL-2 融合蛋白,可驱动抗肿瘤免疫并抑制小细胞肺癌中的肿瘤生长

Yuanwang Pan #, Yuan Hao #, Han Han #, Ting Chen, Hailin Ding, Kristen E Labbe, Elaine Shum, Kayla Guidry, Hai Hu, Fiona Sherman, Ke Geng, Janaye Stephens, Alison Chafitz, Sittinon Tang, Hsin-Yi Huang, Chengwei Peng, Christina Almonte, Jared E Lopes, Heather C Losey, Raymond J Winquist, Vamsidhar Ve